Last update 08 May 2025

Dorzolamide/Latanoprost

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
CAs x PTGFR
Action
inhibitors, agonists
Mechanism
CAs inhibitors(Carbonic anhydrases inhibitors), PTGFR agonists(Prostanoid FP receptor agonists)
Therapeutic Areas
Eye Diseases
Active Indication-
Inactive Indication
Glaucoma, Open-AngleOcular Hypotension
Originator Organization
Alleanza Pharmaceuticals, Inc.
Active Organization-
Inactive Organization
Chong Kun Dang Pharmaceutical Corp.Chong Kun Dang Pharmaceutical Corp.Alleanza Pharmaceuticals, Inc.
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC26H40O5
InChIKeyGGXICVAJURFBLW-CEYXHVGTSA-N
CAS Registry130209-82-4
View All Structures (2)

Related

2
Clinical Trials associated with Dorzolamide/Latanoprost
NCT00348400
/ CompletedPhase 4
Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost
NCT01896180
/ CompletedPhase 2
A Pilot, Single-Masked Study to Compare the Safety and Efficacy of ALZ-1101 (Latanoprost 0.005%/Dorzolamide 2.0%) to Latanoprost Ophthalmic Solution, 0.005% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension With Intraocular Pressure Inadequately Controlled By Latanoprost
100 Clinical Results associated with Dorzolamide/Latanoprost
Login to view more data
100 Translational Medicine associated with Dorzolamide/Latanoprost
Login to view more data
100 Patents (Medical) associated with Dorzolamide/Latanoprost
Login to view more data
100 Deals associated with Dorzolamide/Latanoprost
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Glaucoma, Open-AnglePhase 2
United States
Alleanza Pharmaceuticals, Inc.
01 Jul 2013
Ocular HypotensionPhase 2
United States
Alleanza Pharmaceuticals, Inc.
01 Jul 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free